Frank Hsu
Director/Board Member at Karin Grunebaum Cancer Research Foundation
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joel Peterson | M | 77 |
Stanford University
| 32 years |
Linda M. Dairiki Shortliffe | M | 75 |
Stanford University
| 31 years |
Byoung Yoon Kim | M | - |
Stanford University
| 34 years |
Mari Baker | F | 59 |
Stanford University
| 28 years |
Paulraj Arogyaswami | M | 79 |
Stanford University
| 31 years |
Gunnar E. Carlsson | M | - |
Stanford University
| 33 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter Kiener | M | 72 |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | 4 years |
James Rickey | M | 45 | 6 years | |
Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Puneet Agarwal | M | - |
Stanford University
| 5 years |
Susan Kelley | M | 69 | 3 years | |
William Sibold | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Stephen van Horne | M | - |
Stanford University
| 2 years |
Gary Zweiger | M | - |
Stanford University
| 11 years |
Kurt Zimmerman | M | - |
Stanford University
| 5 years |
Derek R. Armfield | M | - |
Stanford University
| 5 years |
Matthew E. Spiegelman | M | - |
Stanford University
| 5 years |
Sameer Dholakia | M | 50 |
Stanford University
| 4 years |
Boyd Fowler | M | - |
Stanford University
| 5 years |
Chris Jones | M | 56 |
Stanford University
| 5 years |
Benjamin Chelf | M | - |
Stanford University
| 6 years |
Teresa Kong | F | - |
Stanford University
| 5 years |
David Tony Lillios | M | - |
Stanford University
| 5 years |
Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
Jeffrey Bede | M | - |
Stanford University
| 4 years |
Erik Falk | M | 54 |
Stanford University
| 4 years |
Larry Alder | M | - |
Stanford University
| 6 years |
Alex Kunczynski | M | - |
Stanford University
| 5 years |
Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
Van Ton-Quinlivan | M | - |
Stanford University
| 2 years |
Jené Elzie | F | 49 |
Stanford University
| 5 years |
Márcio Gomes Pinto Garcia | M | 64 |
Stanford University
| 3 years |
Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Jennifer Wu | F | - |
Stanford University
| 9 years |
Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
Christopher Whitmore | M | - | - | |
Robert Neivert | M | - |
Stanford University
| 3 years |
Y. Dan Rubinstein | M | - |
Stanford University
| 6 years |
Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
Cipora Herman | F | 50 |
Stanford University
| 5 years |
Chih-Kong Ken Yang | M | - |
Stanford University
| 5 years |
Mauria Finley | F | 50 |
Stanford University
| 5 years |
Ashley Johnson | F | 52 |
Stanford University
| 6 years |
Mark V. Matthews | M | - |
Stanford University
| 6 years |
Lawrence S. Malkin | M | - |
Stanford University
| 4 years |
Eleanor de Groot | M | 55 |
Stanford University
| 5 years |
Tobin C. Island | M | 57 |
Stanford University
| 5 years |
Sasa Zorovic | M | - |
Stanford University
| 6 years |
Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
Ryan A. Harris | M | - |
Stanford University
| 6 years |
Kevin Efrusy | M | 51 |
Stanford University
| 5 years |
Selena Chaisson | M | - |
Stanford University
| 5 years |
William Staib | M | - |
Stanford University
| 4 years |
Kenneth McBride | M | 56 |
Stanford University
| 6 years |
William Ringo | M | 78 | 5 years | |
Jason Terrance Holzer | M | 52 |
Stanford University
| 4 years |
Brian Atwood | M | 71 | 8 years | |
Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
Eric Selmon | M | - |
Stanford University
| 5 years |
Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Lewis Coleman | M | 82 | 4 years | |
Patrick Loulou | M | 55 |
Stanford University
| 4 years |
Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
David ibnAle | M | 52 |
Stanford University
| 5 years |
Franklin Berger | M | 74 | 5 years | |
Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
Alexander Mihai Popovici | M | - |
Stanford University
| 5 years |
Ahmed Farooq | M | - |
Stanford University
| 6 years |
Vincent K. Jones | M | - |
Stanford University
| 5 years |
Robert Kalman | M | - |
Stanford University
| 6 years |
Ravi Belani | M | - |
Stanford University
| 4 years |
Jeff Stevens | M | - |
Stanford University
| 8 years |
Tom Perkins | M | - |
Stanford University
| 3 years |
Anand Rajaraman | M | - |
Stanford University
| 3 years |
Kevin Stein | M | 58 |
Stanford University
| 5 years |
Michael O'Connor | M | - |
Stanford University
| 5 years |
Mark Heinrich | M | - |
Stanford University
| 5 years |
Thomas D. Willis | M | - |
Stanford University
| 3 years |
David Lam | M | - |
Stanford University
| 5 years |
Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
Jessica Baron | F | 48 |
Stanford University
| 4 years |
Kenneth Ehrman | M | 53 |
Stanford University
| 4 years |
Richard A. Moscicki | M | 72 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 19 years |
Andrew F. Drenick | M | 67 |
Stanford University
| 2 years |
Chris O'Neill | M | - |
Stanford University
| 2 years |
Robert Hesslein | M | 71 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 years |
Richard Douglas | M | 71 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
Daria Mochly-Rosen | M | - |
Stanford University
| - |
Gregory T. Hannibal | M | - |
Stanford University
| 4 years |
Michael Panzara | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 7 years |
Ajay Agarwal | M | - |
Stanford University
| 4 years |
Armand Wahyudi Hartono | M | 49 |
Stanford University
| 1 years |
Pulakesh Mukherjee | M | - |
Stanford University
| 5 years |
Sharath Reddy | M | - |
Stanford University
| 4 years |
Hong Bin Cai | M | 56 |
Stanford University
| 3 years |
Karen D. Cheng | M | - |
Stanford University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank Hsu
- Personal Network